BA vs. AUPH
BA (The Boeing Company) and AUPH (Aurinia Pharmaceuticals Inc.) are both stocks. BA operates in Aerospace & Defense (Industrials), while AUPH operates in Biotechnology (Healthcare). Over the past 10 years, BA returned 6.28%/yr vs 18.49%/yr for AUPH. At a 0.21 correlation, their price movements are largely independent.
Performance
BA vs. AUPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BA achieves a 0.89% return, which is significantly higher than AUPH's -0.82% return. Over the past 10 years, BA has underperformed AUPH with an annualized return of 6.28%, while AUPH has yielded a comparatively higher 18.49% annualized return.
BA
- 1D
- -1.16%
- 1M
- -8.96%
- YTD
- 0.89%
- 6M
- 7.18%
- 1Y
- 7.51%
- 3Y*
- -0.20%
- 5Y*
- -2.40%
- 10Y*
- 6.28%
AUPH
- 1D
- -0.19%
- 1M
- -1.31%
- YTD
- -0.82%
- 6M
- -0.19%
- 1Y
- 92.22%
- 3Y*
- 16.72%
- 5Y*
- 4.23%
- 10Y*
- 18.49%
BA vs. AUPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BA The Boeing Company | 0.89% | 22.67% | -32.10% | 36.84% | -5.38% | -5.95% | -33.90% | 3.34% | 11.50% | 94.72% |
AUPH Aurinia Pharmaceuticals Inc. | -0.82% | 77.62% | -0.11% | 108.10% | -81.11% | 65.37% | -31.74% | 197.07% | 50.55% | 115.71% |
Correlation
The correlation between BA and AUPH is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Sep 3, 2014 | 0.21 |
Fundamentals
BA:
$179.22B
AUPH:
$2.18B
BA:
$2.90
AUPH:
$2.15
BA:
75.49
AUPH:
7.37
BA:
11.83
AUPH:
0.00
BA:
1.86
AUPH:
7.37
BA:
29.97
AUPH:
3.84
BA:
$92.18B
AUPH:
$298.30M
BA:
$4.43B
AUPH:
$267.70M
BA:
$7.13B
AUPH:
$153.45M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BA vs. AUPH — Risk / Return Rank
BA
AUPH
BA vs. AUPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for The Boeing Company (BA) and Aurinia Pharmaceuticals Inc. (AUPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BA | AUPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.80 | ||
| Sortino ratioReturn per unit of downside risk | -2.05 | ||
| Omega ratioGain probability vs. loss probability | 1.07 | 1.38 | -0.31 |
| Calmar ratioReturn relative to maximum drawdown | 0.30 | 5.83 | -5.53 |
| Martin ratioReturn relative to average drawdown | 0.69 | 12.68 | -11.99 |
Loading charts...
Drawdowns
BA vs. AUPH - Drawdown Comparison
The maximum BA drawdown since its inception was -89.45%, roughly equal to the maximum AUPH drawdown of -87.58%. Use the drawdown chart below to compare losses from any high point for BA and AUPH.
Loading charts...
Drawdown Indicators
| BA | AUPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.45% | -87.58% | -1.87% |
Max Drawdown (1Y)Largest decline over 1 year | -24.96% | -15.91% | -9.05% |
Max Drawdown (3Y)Largest decline over 3 years | -48.31% | -60.80% | +12.49% |
Max Drawdown (5Y)Largest decline over 5 years | -53.76% | -87.58% | +33.82% |
Max Drawdown (10Y)Largest decline over 10 years | -77.92% | -87.58% | +9.66% |
Current DrawdownCurrent decline from peak | -49.09% | -52.18% | +3.09% |
Average DrawdownAverage peak-to-trough decline | -31.02% | -49.21% | +18.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.95% | 7.30% | +3.65% |
Volatility
BA vs. AUPH - Volatility Comparison
The Boeing Company (BA) has a higher volatility of 12.44% compared to Aurinia Pharmaceuticals Inc. (AUPH) at 9.07%. This indicates that BA's price experiences larger fluctuations and is considered to be riskier than AUPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BA | AUPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.44% | 9.07% | +3.37% |
Volatility (6M)Calculated over the trailing 6-month period | 23.39% | 23.92% | -0.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 32.33% | 45.50% | -13.17% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 36.58% | 67.46% | -30.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.61% | 73.95% | -32.34% |
Dividends
BA vs. AUPH - Dividend Comparison
Neither BA nor AUPH has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AUPH Aurinia Pharmaceuticals Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BA The Boeing Company | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.96% | 2.52% | 2.12% | 1.93% | 2.80% | 2.52% |
Financials
BA vs. AUPH - Financials Comparison
This section allows you to compare key financial metrics between The Boeing Company and Aurinia Pharmaceuticals Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BA vs. AUPH - Profitability Comparison
BA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, The Boeing Company reported a gross profit of 2.55B and revenue of 22.22B. Therefore, the gross margin over that period was 11.5%.
AUPH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aurinia Pharmaceuticals Inc. reported a gross profit of 71.20M and revenue of 77.71M. Therefore, the gross margin over that period was 91.6%.
BA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, The Boeing Company reported an operating income of 448.00M and revenue of 22.22B, resulting in an operating margin of 2.0%.
AUPH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aurinia Pharmaceuticals Inc. reported an operating income of 41.42M and revenue of 77.71M, resulting in an operating margin of 53.3%.
BA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, The Boeing Company reported a net income of -4.00M and revenue of 22.22B, resulting in a net margin of -0.0%.
AUPH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aurinia Pharmaceuticals Inc. reported a net income of 34.36M and revenue of 77.71M, resulting in a net margin of 44.2%.
Frequently Asked Questions
BA and AUPH have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BA has higher volatility (12.44%) compared to AUPH (9.07%). In terms of maximum drawdown, BA dropped -89.45% vs AUPH's -87.58%.
AUPH currently has the higher Sharpe Ratio (2.04 vs 0.24), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BA and AUPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer